Skip to content
Back to search

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Sorafenib (ATC-Code: L01EX02).

AOK Niedersachsen. Die Gesundheitskasse.GermanyPublished on Oct 01, 2026
681 days left

Description

Conclusion of a non-exclusive rebate contract pursuant to Section 130a (8) SGB V for medicinal products containing the active substance Sorafenib (ATC code: L01EX02) within the period from 01.12.2026 to 30.11.2028 with the possibility of concluding the contract at any time during the contract period (open-house model).

CPV codes

Pharmaceutical products
AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders